Market Place
Sourcing Support
Yung Shin Pharm`s Generic Entecavir Receives Approval In US
16 Nov 2021 //
FDA
Pharmadax’s Generic Entecavir Receives Approval In US
13 Aug 2020 //
FDA
5 FDA-approved antivirals could target COVID-19: study
02 Jul 2020 //
FIERCE BIOTECH
Sunshine Lake Generic Entecavir Receives Approval in US
23 May 2020 //
FDA
YaoPharma`s Generic Entecavir Receives Approval in US
07 Nov 2019 //
FDA
Brightgene Bio-Medical`s Generic Entecavir Receives Approval In US
25 Sep 2019 //
FDA
Selling Drugs Is No Longer a Free Lunch in China
03 Jan 2019 //
BLOOMBERG
Chinese Biopharma Stocks Plummet After Centralized Tendering Report
07 Dec 2018 //
BIOCENTURY
CASI, Yiling Wanzhou Enter Agreement
22 Jun 2018 //
PR NEWSWIRE
Breckenridge announces approval of Hep B virus tablets
02 Apr 2018 //
BIOSPECTRUM
Breckenridge`s Announces Final Approval of its ANDA Entecavir tablets Baraclude®
27 Mar 2018 //
PR NEWSWIRE
Prinston’s Generic Entecavir Approval In US
13 Oct 2017 //
FDA
Prinston’s Generic Entecavir Receives Approval In US
13 Oct 2017 //
FDA
Mylan S.A.S`s Entecavir Receives Approval In Europe
11 Oct 2017 //
EMA
Accord’s Generic Entecavir Receives Approval In US
30 Aug 2017 //
FDA
Zydus Pharm’s Generic Entecavir Receives Approval In US
26 Jun 2017 //
FDA
GeoVax draws a bead on hep B with therapeutic vaccine deal
19 Jan 2017 //
FIERCE BIOTECH
Cipla gets US FDA approval for generic Baraclude tablets
08 Dec 2016 //
PHARMABIZ
Cipla`s Generic Entecavir Receives Approval In US
06 Dec 2016 //
FDA
Par`s Generic Entecavir Receives Approval In US
23 Nov 2016 //
FDA
The pill that costs $9,000 in US sells for $70 in India
09 Feb 2016 //
ECONOMIC TIMES
Aurobindo`s strong run to continue
23 Nov 2015 //
BUSINESS STANDARD
Amneal`s Generic Entecavir approved in US for the treatment of chronic hepB
14 Nov 2015 //
FDA
J&J buys firm seeking hepatitis B cure
05 Nov 2015 //
PM LIVE
Aurobindo Pharma gets USFDA nod for hepatitis B drug Entecavir
26 Aug 2015 //
THE ECONOMIC TIMES
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.